Studies in glioma cell lines comparing the MGMT expression and the extent of its promoter methylation have also been performed [17,18]; these investigations have identified two methylated areas in the CpG island: a highly methylated region upstream of the transcription initiation site, including a minimal promoter, and a highly methylated region downstream of exon 1 [19,20]. Here, MGMT is linked to central nervous system cancer.